ProPhase Labs, Inc. (OTC: PRPH)

ProPhase Labs, Inc., often recognized by its stock symbol 'PRPH,' is a forward-thinking and diversified company that operates within the biotech, genomics, and diagnostics industry. The company's operations span across various segments, including ProPhase Diagnostics, Nebula Genomics, PBIO, PMI, and TK Supplements.

ProPhase Labs' primary business activities revolve around the development and commercialization of novel drugs, dietary supplements, and compounds, as well as the provision of diagnostic testing services. ProPhase Diagnostics, a subsidiary of the company, previously offered a range of COVID-19 related clinical diagnostic and testing services. Nebula Genomics, another subsidiary, focuses on genomics testing technologies, while PBIO is responsible for licensing, developing, and commercializing novel drugs, dietary supplements, and compounds. PMI operates as a full-service contract manufacturer and private label developer of various non-GMO, organic, and natural-based products. TK Supplements is a brand that offers a variety of herbal supplements.

The company generates revenue through a diverse range of products and services. Its primary products and services include COVID-19 testing, genomics testing technologies, contract manufacturing, and herbal supplements. Specific product names include Equivir, a dietary supplement candidate, and Equivir G, a prescription drug candidate, both of which are blends of polyphenols. The company also develops Linebacker LB-1 and LB-2, small molecule proviral integration site for moloney murine leukemia virus (PIM) kinase inhibitors product candidates. TK Supplements offers products such as Legendz XL, a male sexual enhancement supplement, and Triple Edge XL, an energy and stamina booster.

ProPhase Labs' competitive advantages stem from its expertise in genomics and its ability to develop and commercialize novel products. The company competes with commercial laboratories like Quest Diagnostics Incorporated and Laboratory Corporation of America Holdings, large multispecialty group medical clinics and health systems, regional clinical laboratories providing diagnostic services, and other contract manufacturers of OTC drug and dietary supplement products.

The company's customers encompass a wide range of healthcare providers, including hospitals, clinics, and physician offices, as well as retail customers such as pharmacies and health food stores.

ProPhase Labs' product portfolio includes brands such as Equivir, Equivir G, Linebacker LB-1, Linebacker LB-2, and TK Supplements' Legendz XL and Triple Edge XL. These brands highlight the company's commitment to developing and commercializing novel and innovative products.